Precision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality? [0.03%]
精准医学与非结直肠癌肝转移：是真是假？
Effie Liakopoulou,Alexander Knuth
Effie Liakopoulou
Background: Non-colorectal liver metastases (nCRLM) constitute a variety of heterogeneous diseases and a considerable therapeutic challenge. Management is based on the primary tumor and the clinical course. In the era of ...
Current Medical Treatment of Patients with Non-Colorectal Liver Metastases: Primary Tumor Breast Cancer [0.03%]
非结直肠肝转移患者当前的治疗方法：原发肿瘤为乳腺癌患者的治疗
Cornelia Liedtke,Hans-Christian Kolberg
Cornelia Liedtke
Background: (Metastatic) breast cancer is a heterogeneous entity in which every disease subtype requires an individualized systemic treatment approach. Me...
Gilbert Puippe,Thomas Pfammatter,Niklaus Schaefer
Gilbert Puippe
Background: The unique situation of the liver with arterial and venous blood supply and the dependency of the tumor on the arterial blood flow make this organ an ideal target for intrahepatic catheter-based therapies. Mai...
How Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases? [0.03%]
非结直肠癌肝转移患者的经皮肝脏定向治疗的有效性如何？
Thomas J Vogl,Ahmed Emam,Nagy N Naguib et al.
Thomas J Vogl et al.
Background: The purpose of this review is to demonstrate the clinical indications, technical developments, and outcome of liver-directed therapies in interventional oncology of non-colorectal liver metastases. ...
Is There a Role for Liver Transplantation in Non-Colorectal Liver Metastases? [0.03%]
肝移植在非结直肠癌肝转移中的作用？
Uta Herden,Björn Nashan
Uta Herden
Due to the high blood flow, especially blood from the intestinal tract via the portal vein, the liver is a preferred organ for metastases. In case of advanced, irresectable liver metastases liver transplantation (LTX) remains an attractive ...
Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications [0.03%]
非结直肠肝转移的切除治疗-标准和扩大适应证
Ulf Kulik,Frank Lehner,Hüseyin Bektas et al.
Ulf Kulik et al.
Background: Due to the uncertain benefit of liver resection for non-colorectal liver metastases (NCLM), patient selection for surgery is generally difficult. Therefore, the aim of this article was to propose standard and ...
Philipp Heusch,Gerald Antoch
Philipp Heusch
Liver metastases are the most frequent malignant liver lesions. Besides colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, breast cancer, lung cancer, and neuroendocrine tumors are the most common entities that metastasize to th...
Andrea Frilling,Matthias Ebert
Andrea Frilling
Philipp Solbach,Heiner Wedemeyer
Philipp Solbach
Background: Within the development and approval of several new direct-acting antivirals (DAA) against hepatitis C virus (HCV), a new era of hepatitis C therapy has begun. Even more treatment options are likely to become a...
Georg Lamprecht,Raja Atreya,Martin E Kreis et al.
Georg Lamprecht et al.